The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (5): 695-701.doi: 10.3969/j.issn.1006-5725.2024.05.018
• Investigations • Previous Articles Next Articles
Yan LI1,2,Qi WANG1,Lu ZHENG1,2(),Lihui FENG1,Li MA1,Jian WEI1,2,Liangshu. LIU1
Received:
2023-06-17
Online:
2024-03-10
Published:
2024-03-26
Contact:
Lu ZHENG
E-mail:zhenglu0803@163.com
CLC Number:
Yan LI,Qi WANG,Lu ZHENG,Lihui FENG,Li MA,Jian WEI,Liangshu. LIU. Correlation between IL-17 gene polymorphism and type 2 diabetes mellitus in Han population in southeast Shanxi Province[J]. The Journal of Practical Medicine, 2024, 40(5): 695-701.
Tab.1
Comparison of general dataand biochemical indexes"
观察指标 | CON | T2DM | χ2/t值 | P值 |
---|---|---|---|---|
例数(男/女) | 103(60/43) | 101(61/40) | 0.097 | 0.755 |
年龄(岁) | 40.25 ± 8.50 | 42.34 ± 7.78 | 1.831 | 0.069 |
BMI(kg/m2) | 23.21 ± 3.05 | 25.71 ± 3.35 | 5.272 | < 0.001 |
WC(cm) | 81.68 ± 8.97 | 92.44 ± 9.31 | 8.411 | < 0.001 |
HC(cm) | 97.40 ± 6.52 | 97.74 ± 10.74 | 0.270 | 0.788 |
WHR | 0.84 ± 0.05 | 0.99 ± 0.51 | 2.960 | 0.003 |
FPG(mmol/L) | 4.79 ± 0.36 | 10.03 ± 3.32 | 15.945 | < 0.001 |
2hPG(mmol/L) | 5.53 ± 0.59 | 18.59 ± 4.47 | 29.346 | < 0.001 |
HbA1c(%) | 5.66 ± 0.65 | 9.14 ± 1.91 | 17.483 | < 0.001 |
FIns(mIU/L) | 5.92 ± 3.22 | 11.64 ± 4.67 | 10.200 | < 0.001 |
HOMA?IR | 1.26 ± 0.07 | 5.02 ± 0.23 | 16.058 | < 0.001 |
HOMA?β | 100.01 ± 6.46 | 53.07 ± 5.80 | 5.399 | < 0.001 |
TG(mmol/L) | 1.15 ± 0.36 | 2.11 ± 1.80 | 5.291 | < 0.001 |
TC(mmol/L) | 3.87 ± 0.66 | 4.82 ± 1.37 | 6.350 | < 0.001 |
HDL?C(mmol/L) | 1.33 ± 0.25 | 1.03 ± 0.22 | 9.146 | < 0.001 |
LDL?C(mmol/L) | 2.57 ± 0.53 | 3.12 ± 0.96 | 5.067 | < 0.001 |
Tab.2
Overall distribution of genotype and allele frequency of IL-17 gene"
多态性位点 | 基因型频率 | 等位基因频率频次 | |||
---|---|---|---|---|---|
CC | TC | TT | C | T | |
rs2275913 | 66(32.4) | 100(49.0) | 38(18.6) | 232(56.9) | 176(43.1) |
rs3819024 | 66(32.3) | 103(54.5) | 35(17.2) | 235(57.6) | 173(42.4) |
rs4711998 | 91(44.6) | 92(45.1) | 21(10.3) | 274(67.2) | 134(32.8) |
rs8193036 | 84(41.1) | 95(46.6) | 25(12.3) | 263(64.5) | 145(35.5) |
Tab.3
The genotype and allele frequency distribution of IL-17 gene n the two groups"
SNP位点 | 等位基因/基因型 | 频率[n(%)] | χ2值 | P值 | |
---|---|---|---|---|---|
CON | T2DM | ||||
rs2275913 | A | 92(44.7) | 84(41.6) | 0.393 | 0.531 |
G | 114(55.3) | 118(58.4) | |||
AA | 22(21.4) | 16(15.8) | 1.088 | 0.580 | |
AG | 48(24.6) | 52(51.5) | |||
GG | 33(32.0) | 33(32.7) | |||
rs3819024 | A | 116(57.4) | 119(57.8) | 0.034 | 0.853 |
G | 87(42.2) | 86(42.6) | |||
AA | 33(32.7) | 33(32.0) | 0.096 | 0.953 | |
GA | 53(51.5) | 50(49.5) | |||
GG | 17(16.5) | 18(17.8) | |||
rs4711998 | A | 141(68.4) | 133(65.8) | 0.314 | 0.575 |
G | 65(31.6) | 69(34.2) | |||
AA | 45(43.7) | 46(45.5) | 3.412 | 0.182 | |
AG | 51(49.5) | 41(40.6) | |||
GG | 7(6.8) | 14(13.9) | |||
rs8193036 | C | 130(64.4) | 133(64.6) | 0.310 | 0.965 |
T | 73(35.4) | 72(35.6) | |||
CC | 42(41.6) | 42(40.8) | 0.115 | 0.944 | |
TC | 49(47.6) | 46(45.5) | |||
TT | 12(11.7) | 13(12.9) |
Tab.4
Comparison of the genotype frequency of IL-17 gene SNP locus between the two groups under different genetic models"
分组 | rs2275913 | ||||||
---|---|---|---|---|---|---|---|
共显性模型 | 显性模型 | 隐性模型 | |||||
AA | AG | GG | GG | AA,AG | GG,AG | AA | |
CON | 22(21.4) | 48(24.6) | 33(32.0) | 33(32.0) | 70(68.0) | 81(78.6) | 22(21.4) |
T2DM | 16(15.8) | 52(51.5) | 33(32.7) | 33(32.7) | 68(67.3) | 85(84.2) | 16(15.8) |
OR(95%CI) | 0.72(0.26~2.00) | 0.60(0.19~190) | 1 | 1 | 1.02(0.89~1.17) | 1 | 1.03(0.94~1.14) |
P值 | 0.300 | 0.768 | _ | _ | 0.923 | _ | 0.496 |
P′值 | 0.289 | 0.526 | _ | _ | 0.731 | _ | 0.313 |
Tab.5
Comparison of clinical index levels among each genotype of IL-17 gene SNP locus in T2DM population"
相关指标 | rs2275913基因型 | F值 | P值 | ||
---|---|---|---|---|---|
AA | GA | GG | |||
BMI(kg/m2) | 25.95 ± 3.68 | 25.55 ± 3.01 | 26.51 ± 3.70 | 0.594 | 0.325 |
WC(cm) | 90.03 ± 1.86 | 92.27 ± 9.38 | 93.89 ± 8.38 | 0.945 | 0.416 |
FPG(mmol/L) | 8.02 ± 0.66 | 10.27 ± 0.46 | 10.63 ± 0.58a | 3.791 | 0.026 |
HbA1c(%) | 8.84 ± 0.63 | 9.12 ± 0.24 | 9.32 ± 0.33 | 0.335 | 0.716 |
FINS(mIU/L) | 10.10 ± 1.07 | 11.75 ± 0.68 | 12.22 ± 0.76 | 1.133 | 0.326 |
HOMA?IR | 3.51 ± 0.44 | 5.13 ± 0.31 | 5.57 ± 0.40a | 4.928 | 0.009 |
HOMA?β | 64.99 ± 11.66 | 47.66 ± 5.58 | 58.84 ± 13.81 | 0.591 | 0.556 |
相关指标 | rs3819024基因型 | F值 | P值 | ||
AA | GA | GG | |||
BMI(kg/m2) | 26.67 ± 3.47 | 25.84 ± 3.23 | 25.17 ± 3.27 | 1.377 | 0.188 |
WC(cm) | 95.26 ± 8.10 | 92.04 ± 9.01 | 88.41 ± 10.90a | 3.401 | 0.032 |
FPG(mmol/L) | 11.07 ± 0.52 | 9.68 ± 0.46 | 9.10 ± 0.90 | 2.694 | 0.073 |
HbA1c(%) | 9.54 ± 0.33 | 8.83 ± 0.24 | 9.28 ± 0.56 | 1.438 | 0.242 |
FINS(mIU/L) | 11.35 ± 0.73 | 12.36 ± 0.69 | 10.20 ± 1.10 | 1.530 | 0.222 |
HOMA?IR | 5.49 ± 0.39 | 5.14 ± 0.31 | 3.83 ± 0.50a | 3.407 | 0.037 |
HOMA?β | 38.84 ± 3.73 | 58.77 ± 9.53 | 68.86 ± 16.83 | 2.407 | 0.095 |
相关指标 | rs4711998基因型 | F值 | P值 | ||
AA | AG | GG | |||
BMI(kg/m2) | 26.12 ± 3.27 | 25.76 ± 3.27 | 26.33 ± 3.27 | 0.197 | 0.648 |
WC(cm) | 92.75 ± 3.17 | 91.61 ± 3.21 | 93.88 ± 3.33 | 0.350 | 0.786 |
FPG(mmol/L) | 9.78 ± 0.55 | 10.04 ± 0.47 | 10.83 ± 0.79 | 0.541 | 0.584 |
HbA1c(%) | 9.37 ± 0.31 | 8.68 ± 0.23 | 9.72 ± 0.61 | 2.209 | 0.115 |
FIns(mIU/L) | 11.46 ± 0.62 | 11.39 ± 0.79 | 12.98 ± 1.36 | 0.663 | 0.517 |
HOMA?IR | 4.74 ± 0.30 | 4.95 ± 0.36 | 6.11 ± 0.72 | 2.045 | 0.134 |
HOMA?β | 55.73 ± 7.38 | 53.59 ± 11.50 | 42.85 ± 6.65 | 0.261 | 0.771 |
相关指标 | rs8193036基因型 | F值 | P值 | ||
CC | TC | TT | |||
BMI(kg/m2) | 25.80 ± 3.14 | 26.14 ± 3.66 | 26.16 ± 2.78 | 0.127 | 0.781 |
WC(cm) | 91.00 ± 8.88 | 93.37 ± 9.78 | 93.82 ± 9.02 | 0.870 | 0.244 |
FPG(mmol/L) | 10.44 ± 0.58 | 9.37 ± 0.40 | 11.04 ± 0.95 | 1.855 | 0.257 |
HbA1c(%) | 9.41 ± 0.31 | 8.8 ± 0.25 | 9.46 ± 0.64 | 1.349 | 0.407 |
FIns(mIU/L) | 10.96 ± 0.83 | 12.0 ± 0.54 | 12.58 ± 1.49 | 0.839 | 0.336 |
HOMA?IR | 4.81 ± 0.38 | 4.92 ± 0.28 | 6.02 ± 0.77 | 1.508 | 0.315 |
HOMA?β | 50.97 ± 8.42 | 58.49 ± 10.0 | 40.76 ± 6.80 | 0.511 | 0.190 |
1 |
HUBACEK J A, DLOUHA L, ADAMKOVA V, et al. Genetic risk score is associated with T2DM and diabetes complications risks [J]. Gene, 2023, 849: 146921. doi:10.1016/j.gene.2022.146921
doi: 10.1016/j.gene.2022.146921 |
2 |
董国庆, 黄秒, 陆喜燕. 基因检测在儿童糖尿病中的研究进展及临床评估 [J]. 实用医学杂志, 2023, 39(2): 148-152. doi:10.3969/j.issn.1006-5725.2023.02.004
doi: 10.3969/j.issn.1006-5725.2023.02.004 |
3 | MAHAJAN A, TALIUN D, THURNER M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps [J]. Nat Genet, 2018, 50(11): 1505-1513. |
4 |
CHEN Y, CHEN X Y, DONG X L, et al. Investigation of the Association between 45 Tag SNPs and Type 2 Diabetes Mellitus in Han Chinese Adults: A Prospective Cohort Study [J]. Public Health Genomics, 2021, 24(3-4): 123-130. doi:10.1159/000513891
doi: 10.1159/000513891 |
5 |
JAN A, ZAKIULLAH, KHUDA F, et al. Validation of Genome-Wide Association Studies (GWAS)-Identified Type 2 Diabetes Mellitus Risk Variants in Pakistani Pashtun Population [J]. J ASEAN Fed Endocr Soc, 2023, 38(1): 55-61. doi:10.15605/jafes.037.s5
doi: 10.15605/jafes.037.s5 |
6 |
SORSKI L, GIDRON Y. The Vagal Nerve, Inflammation, and Diabetes-A Holy Triangle [J]. Cells, 2023, 12(12) :1632. doi:10.3390/cells12121632
doi: 10.3390/cells12121632 |
7 |
MYERS J L, XIA H, CABALLERO M Y, et al. A Military Community Cohort Study Reveals Single Nucleotide Polymorphisms in Inflammation Mediator Genes That Associate With Type 2 Diabetes [J]. Mil Med, 2022 :usac299. doi:10.1093/milmed/usac299
doi: 10.1093/milmed/usac299 |
8 |
CHATTERJEE T, DE D, CHOWDHURY S, et al. Nuclear factor NF-κB1 functional promoter polymorphism and its expression conferring the risk of Type 2 diabetes-associated dyslipidemia [J]. Mamm Genome, 2020, 31(7-8): 252-262. doi:10.1007/s00335-020-09846-0
doi: 10.1007/s00335-020-09846-0 |
9 |
MILLS K H G. IL-17 and IL-17-producing cells in protection versus pathology [J]. Nat Rev Immunol, 2023, 23(1): 38-54. doi:10.1038/s41577-022-00746-9
doi: 10.1038/s41577-022-00746-9 |
10 |
ARIKAN S, ÖZTÜRK O, DUYGULU Ş, et al. Associations of IL-17 and IL-17 receptor polymorphisms with Behçet's disease in Denizli Province of Turkey [J]. Immunol Res, 2023, 71(4): 600-608. doi:10.1007/s12026-023-09363-7
doi: 10.1007/s12026-023-09363-7 |
11 |
ZAPATA-SALAZAR N A, KUBELIS-LOPEZ D E, SALINAS-SANTANDER M A, et al. Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population [J]. Arch Dermatol Res, 2023, 315(3): 447-454. doi:10.1007/s00403-022-02382-8
doi: 10.1007/s00403-022-02382-8 |
12 | LI J, XU L, ZHAO W, et al. Serum IL-17A concentration and a IL17RA single nucleotide polymorphism contribute to the risk of autoimmune type 1 diabetes [J]. Diabetes Metab Res Rev, 2022, 38(6): e3547. |
13 |
ABDELLAH H A A, MOHAMED M F, ESMAIL M A, et al. Association of IL-17A rs2275913, IL-23R rs11209026 polymorphisms and serum level of IL-17A with rheumatoid arthritis in Egyptian patients [J]. Egypt J Immunol, 2023, 30(3): 134-147. doi:10.55133/eji.300314
doi: 10.55133/eji.300314 |
14 |
ALEKSANDROVA E, VLAYKOVA T, ANANIEV J, et al. Protective Role of IL7A-197 A/G Heterozygosity in the Development and Severity of Colorectal Cancer in the Bulgarian Population [J]. Medicina (Kaunas), 2022, 58(11) :1632. doi:10.3390/medicina58111632
doi: 10.3390/medicina58111632 |
15 |
CAKMAK GENC G, KARAKAS CELIK S, YILMAZ B, et al. Investigation of the relationship between IL17A, IL17F and ILR1N polymorphisms and COVID-19 severity: The predictive role of IL17A rs2275913 polymorphism in the clinical course of COVID-19 [J]. Int J Immunogenet, 2023, 50(3): 117-126. doi:10.1111/iji.12619
doi: 10.1111/iji.12619 |
16 |
RIMACHI HIDALGO M A, CIRELLI T, SILVA B R DA, et al. Polymorphisms and haplotypes in the Interleukin 17 Alfa gene: potential effect of smoking habits in the association with periodontitis and type 2 diabetes mellitus [J]. Mol Biol Rep, 2021, 48(2): 1103-1114. doi:10.1007/s11033-021-06172-9
doi: 10.1007/s11033-021-06172-9 |
17 |
WANG W, DENG G, ZHANG G, et al. Genetic polymorphism rs8193036 of IL17A is associated with increased susceptibility to pulmonary tuberculosis in Chinese Han population [J]. Cytokine, 2020, 127: 154956. doi:10.1016/j.cyto.2019.154956
doi: 10.1016/j.cyto.2019.154956 |
18 |
LI H M, WANG L J, HUANG Q, et al. Exploring the association between Th17 pathway gene polymorphisms and pulmonary tuberculosis [J]. Front Immunol, 2022, 13: 994247. doi:10.3389/fimmu.2022.994247
doi: 10.3389/fimmu.2022.994247 |
[1] | Menglu ZHU,Fengjiao ZHANG,Zhiqiang KANG. Effects of telomere length and plasma AGEs on bone mineral density in type 2 diabetic patients [J]. The Journal of Practical Medicine, 2024, 40(20): 2860-2866. |
[2] | Liehua LIU,Yanbing. LI. Remission of type 2 diabetes: Contending perspectives and practical approaches [J]. The Journal of Practical Medicine, 2024, 40(16): 2206-2210. |
[3] | Tingting YANG,Yidan HUANG,Rongrong YANG,Ying YANG,Jing. ZHANG. Study on the relationship between serum LRG1, LDH with periodontal indexes and periodontal lesions in patients with type 2 diabetes and chronic periodontitis [J]. The Journal of Practical Medicine, 2024, 40(16): 2250-2255. |
[4] | Jing GUI,Feng WANG,Hui YANG,Yumao CAI,Chuangyue. HONG. Investigation of oxidised low⁃density lipoprotein as a risk assessment indicator in patients with type 2 diabetes mellitus combined with pulmonary tuberculosis [J]. The Journal of Practical Medicine, 2024, 40(14): 1995-2002. |
[5] |
LIN Danhong, QUAN Huibiao, OU Qianying, CEN Chaoping, CHEN Kaining..
Effect of liraglutide on testosterone level and sexual function in overweight or obese men with type 2 diabe⁃ tes mellitus [J]. The Journal of Practical Medicine, 2023, 39(7): 894-898. |
[6] |
NIU Chunyan, CHEN Yao, SONG Yongqiang..
Key points of the American Association of Clinical Endocrinology Clinical Practice Guideline for the diagno⁃ sis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings co ⁃sponsored [J]. The Journal of Practical Medicine, 2023, 39(3): 267-273. |
[7] | Yan YANG,Zhen WANG,Defeng. WANG. Clinical research progress of bexagliflozin: A new hypoglycemic drug [J]. The Journal of Practical Medicine, 2023, 39(22): 3015-3020. |
[8] |
BAI Chuan⁃ min, YANG Huijun, WU Bin..
Research progress on relationship between adipokines Adipsin and type 2 diabetes mellitus [J]. The Journal of Practical Medicine, 2023, 39(2): 133-136. |
[9] |
ZHOU Yingni, SHI Min, LAI Jingbo, LI Xiaomiao, LIU Xiangyang. .
Efficacy of PEX168 combined with metformin in newly diagnosed obese patients with type 2 diabetes melli⁃ tus [J]. The Journal of Practical Medicine, 2023, 39(2): 170-174. |
[10] |
DUAN Weizhe, WANG Zhongjing.
Effect of insulin digitalis combined with lilalutide on type 2 diabetes patients with poor blood glucose con⁃trol
[J]. The Journal of Practical Medicine, 2023, 39(2): 175-179.
|
[11] | WANG Peipei, HUA Fei, HUANG Xia, GE Junyi, ZHAO Lu, GU Min. . Research progress of oral microenvironment in patients with type 2 diabetes mellitus and chronic periodon⁃ titis [J]. The Journal of Practical Medicine, 2023, 39(10): 1320-1324. |
[12] |
WANG Min, KUANG Haobin, YUAN Yuan, FENG Zhiyu, CAI Xiaoting, ZHANG Hong, WU Di, CHEN Zeying, HUANG Xianlin, TAN Shouyong. .
The clinical characteristics of type 2 diabetes complicated with pulmonary tuberculosis during treatment with metformin [J]. The Journal of Practical Medicine, 2022, 38(16): 2061-2065. |
[13] |
CHEN Yuyi, XIE Jian, LIANG Xiu′ e. .
Impact of nursing intervention based on information⁃motivation⁃behavioral skills model onmaternal⁃infant delivery outcomesinpatients with gestational diabetes mellitus [J]. The Journal of Practical Medicine, 2022, 38(14): 1731-1735. |
[14] |
WU Qian, GAO Yumin, LI Wuyuntana, PANG Hui, ZHAO Yanping, YU Pei⁃ yao, WANG Zhidi, CHEN Le, ZHAO Lingyan..
Study on the interaction of leptin receptor and adiponectin receptor gene polymorphisms with type 2 diabe⁃ tes in Mongolian population [J]. The Journal of Practical Medicine, 2022, 38(1): 57-61. |
[15] |
ZHANG Hongli, LU Liang, CAO Hui, FANG Chunju, ZHU Haizhen, LI Yong. .
Relationship between p53 Arg72Pro gene polymorphism and chemoradiotherapy sensitivity of cervical can⁃ cer [J]. The Journal of Practical Medicine, 2021, 37(9): 1159-1163. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||